A new treatment for prostate cancer developed and trialled in London has been licensed for use.
Enzalutamide was developed by researchers at the Royal Marsden and University College London hospitals.
The one a day pill checks the spread of the cancer.
Reseachers say the most exciting aspect of this new drug is that is has very few side effects- unlike many cancer treatements.
More top news
The 52-year-old had previous convictions for violence but was not on the anti-terror watchlist.
In a statement Charlton Athletic said: Keith was a true hero who will be greatly missed by all the Charlton family and everyone at the club.
London and the worlds has united on Twitter in defiance of the West minster attack #prayforlondon #wearenotafraid